Speaker

Elizabeth Halvorsen

Vice President - Translational Biology, Seres Therapeutics

Elizabeth Halvorsen, Vice President - Translational Biology at Seres Therapeutics, is speaking at 11th Microbiome Movement USA Summit (Boston, United States of America, 9–11 Nov 2026) in the session “Advancing Microbiome Therapeutics Through Deep Clinical Datasets & Reverse Translational Approaches to Drive LBP Development Success”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Pharmacy & Pharmaceutical Sciences

Upcoming appearances

11th Microbiome Movement USA Summit
9–11 Nov 2026Boston, United States of America
- SpeakerAdvancing Microbiome Therapeutics Through Deep Clinical Datasets & Reverse Translational Approaches to Drive LBP Development Success

More speakers at 11th Microbiome Movement USA Summit

Maria Andrea Azcarate Peril
Professor of Microbiology, University of North Carolina - Chapel Hill
Andrew Bartko
Executive Director, Center for Microbiome Innovation
Ken Blount
Senior Vice President, Head of Microbiome Clinical & Product Development, Ferring Pharmaceuticals
Daniel Brownell
Senior Director - Research & Development, AOBiome Therapeutics
Philip Burnham
Chief Scientific Officer, Kanvas Biosciences
Paul Carlson
Principal Investigator, US Food & Drug Administration (FDA)

See all 26 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Elizabeth Halvorsen, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].